Meeting
Abstract Number: A9
SHM Converge 2022
Background: Elevated proinflammatory cytokines, including IL-6, are associated with significant morbidity and mortality in COVID-19, and it is hypothesized that blocking the inflammatory pathway may prevent disease progression[1]. IL 6 inhibitors were proposed as a treatment option for hospitalized patients to improve patient-centered outcomes[1]. Few studies that investigated the safety of tocilizumab showed heterogeneous results[2,3]. […]
Abstract Number: D41
SHM Converge 2022
Case Presentation: A 52-year-old man with a history of hypertension and coronavirus disease 2019 (COVID-19) two months prior presented to the emergency department (ED) with five days of fever, malaise, vomiting, and diarrhea. He tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) three days prior and received monoclonal antibody infusion the day prior […]
Abstract Number: K36
SHM Converge 2022
Case Presentation: A 76-year-old Hispanic male with a past medical history of well-controlled hypertension, Pre-diabetes, class 3 obesity, unprovoked Deep vein thrombosis (DVT) progressing to pulmonary embolism (PE) diagnosed 6 months ago, treated with apixaban, presented to the ED with 2 weeks history of progressively worsening dyspnea, dry cough and orthopnea. Denies any chest pain, […]
Abstract Number: M32
SHM Converge 2022
Case Presentation: A healthy 32-year-old male presented with fever and myalgia followed by multiple episodes of vomiting and diarrhea for the past few days. On admission, patient had a fever of 101F, tachycardia of 118, blood pressure of 118/66 mmHg. His oxygen saturation was 100% on room air. Physical exam was unremarkable. COVID-19 test was […]